Lurker Nancy

Alkermes plc ยท Director

Lurker Nancy is listed in public filings as director. This Lurker Nancy insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Alkermes plc (ALKS), Collegium Pharmaceutical, Inc. (COLL), and EyePoint Pharmaceuticals, Inc. (EYPT). Investors use Lurker Nancy's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alkermes plcALKS--6.1k sharesGrant / ExerciseMay 21, 2026Disclosure amount unavailable6.1k shares----
Alkermes plcALKS$673k18.2k sharesGrant / ExerciseMay 21, 2026$54.5K1.5k shares$36.95--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alkermes plcALKS$427k11.5k sharesGrant / ExerciseMay 20, 2026$426.7K11.5k shares$36.98--
Alkermes plcALKS--5.4k sharesGrant / ExerciseMay 20, 2026Disclosure amount unavailable5.4k shares----
Collegium Pharmaceutical, Inc.COLL--26.8k sharesGrant / ExerciseMay 14, 2026Disclosure amount unavailable8.7k shares----
Collegium Pharmaceutical, Inc.COLL$648k18k sharesSellMay 13, 2026$161.9K4.5k shares$35.97--
Alkermes plcALKS--3.8k sharesGrant / ExerciseApr 11, 2026Disclosure amount unavailable3.8k shares----
Alkermes plcALKS$452k13.6k sharesGrant / ExerciseApr 11, 2026$30.1K901 shares$33.36--
EyePoint Pharmaceuticals, Inc.EYPT--75.1k sharesGrant / ExerciseJan 6, 2026Disclosure amount unavailable75.1k shares----
EyePoint Pharmaceuticals, Inc.EYPT--12.7k sharesGrant / ExerciseJan 5, 2026Disclosure amount unavailable12.7k shares----
EyePoint Pharmaceuticals, Inc.EYPT$699k40k sharesGrant / ExerciseJan 2, 2026$699.2K40k shares$17.48--
EyePoint Pharmaceuticals, Inc.EYPT$3.1M206.5k sharesSellDec 4, 2025$140.5K9.3k shares$15.11--
EyePoint Pharmaceuticals, Inc.EYPT$3.2M215.8k sharesSellNov 28, 2025$7.5K500 shares$14.95--
EyePoint Pharmaceuticals, Inc.EYPT$3.2M216.3k sharesSellNov 26, 2025$3.0K200 shares$14.95--
EyePoint Pharmaceuticals, Inc.EYPT--11.1k sharesGrant / ExerciseJul 10, 2025Disclosure amount unavailable11.1k shares----
EyePoint Pharmaceuticals, Inc.EYPT$405k40k sharesGrant / ExerciseJul 2, 2025$557.1K55k shares$10.13--
EyePoint Pharmaceuticals, Inc.EYPT$556k27.3k sharesGrant / ExerciseJul 2, 2025$556.3K27.3k shares$20.40--
EyePoint Pharmaceuticals, Inc.EYPT$031.2k sharesGrant / ExerciseJul 2, 2025$409.2K31.2k shares$13.13--
EyePoint Pharmaceuticals, Inc.EYPT$582k178.4k sharesGrant / ExerciseJul 2, 2025$336.8K103.3k shares$3.26--
EyePoint Pharmaceuticals, Inc.EYPT$291k31.9k sharesGrant / ExerciseJul 2, 2025$139.2K15.3k shares$9.11--
Alkermes plcALKS--8k sharesGrant / ExerciseMay 31, 2025Disclosure amount unavailable8k shares----
Alkermes plcALKS$328k10.7k sharesGrant / ExerciseMay 31, 2025$58.9K1.9k shares$30.61--
Alkermes plcALKS$411k13.5k sharesGrant / ExerciseMay 21, 2025$411.4K13.5k shares$30.53--
Alkermes plcALKS--6.1k sharesGrant / ExerciseMay 21, 2025Disclosure amount unavailable6.1k shares----
Collegium Pharmaceutical, Inc.COLL--22.5k sharesGrant / ExerciseMay 15, 2025Disclosure amount unavailable9.8k shares----
Alkermes plcALKS--2.3k sharesGrant / ExerciseApr 11, 2025Disclosure amount unavailable2.3k shares----
Alkermes plcALKS--5.5k sharesGrant / ExerciseApr 11, 2025Disclosure amount unavailable3.8k shares----
Alkermes plcALKS$125k4.6k sharesGrant / ExerciseApr 11, 2025$24.3K901 shares$27.00--
Alkermes plcALKS$48k1.8k sharesGrant / ExerciseApr 11, 2025$15.1K558 shares$27.00--
EyePoint Pharmaceuticals, Inc.EYPT--20k sharesGrant / ExerciseFeb 9, 2025Disclosure amount unavailable20k shares----
Collegium Pharmaceutical, Inc.COLL--12.7k sharesGrant / ExerciseFeb 4, 2025Disclosure amount unavailable12.7k shares----
EyePoint Pharmaceuticals, Inc.EYPT--75.1k sharesGrant / ExerciseJan 6, 2025Disclosure amount unavailable75.1k shares----
EyePoint Pharmaceuticals, Inc.EYPT--25.3k sharesGrant / ExerciseJan 5, 2025Disclosure amount unavailable12.7k shares----
EyePoint Pharmaceuticals, Inc.EYPT$330k40k sharesGrant / ExerciseJan 3, 2025$330.4K40k shares$8.26--
EyePoint Pharmaceuticals, Inc.EYPT$769k97.6k sharesBuyAug 16, 2024$25.0K3.2k shares$7.88--
EyePoint Pharmaceuticals, Inc.EYPT$409k31.2k sharesGrant / ExerciseJul 26, 2024$350.7K26.7k shares$13.13--
EyePoint Pharmaceuticals, Inc.EYPT$962k95k sharesGrant / ExerciseJul 26, 2024$303.9K30k shares$10.13--
EyePoint Pharmaceuticals, Inc.EYPT$551k169.1k sharesGrant / ExerciseJul 26, 2024$183.7K56.4k shares$3.26--
EyePoint Pharmaceuticals, Inc.EYPT$152k16.7k sharesGrant / ExerciseJul 26, 2024$151.8K16.7k shares$9.11--
EyePoint Pharmaceuticals, Inc.EYPT$01.6k sharesGrant / ExerciseJul 26, 2024$20.1K1.6k shares$12.90--
EyePoint Pharmaceuticals, Inc.EYPT--22.2k sharesGrant / ExerciseJul 10, 2024Disclosure amount unavailable11.1k shares----